CELLS TISSUES ORGANS is a renowned academic journal published by KARGER, focusing on pivotal research within the fields of Anatomy and Histology. Based in Switzerland, this journal has been disseminating influential scientific findings since 1889, contributing to our understanding of cellular structures and tissue functionality. With a current impact factor that places it in the Q2 quartile for both disciplines, it serves as a vital resource for researchers, professionals, and students seeking to stay abreast of significant advancements and discussions in these areas. The journal embraces an Open Access model, ensuring that high-quality, peer-reviewed articles are freely available, thus enhancing visibility and accessibility of critical research. As it continues to foster scholarly communication and innovation up to 2024, CELLS TISSUES ORGANS plays a crucial role in shaping the future of biological sciences and medical research.

NATURE REVIEWS MOLECULAR CELL BIOLOGY, published by NATURE PORTFOLIO, stands as a seminal journal in the fields of cell and molecular biology, with a significant impact factor that underscores its influence and reputation within the scientific community. Established in 2000 and continuing its legacy into 2024, this journal delivers comprehensive reviews that synthesize current knowledge and advancements in molecular and cellular processes. Respected for its high-quality articles, it has maintained a prestigious Q1 ranking in both Cell Biology and Molecular Biology categories as of 2023. With an exceptional Scopus ranking, taking the top position in its category, it attracts a readership of prominent researchers, professionals, and students eager to stay abreast of groundbreaking discoveries and methodologies. Although it does not offer Open Access, subscribers benefit from exclusive access to vital insights that foster innovative research approaches and advancements in the life sciences. The journal’s objective is to bridge the gap between research and application, providing indispensable resources to its audience while contributing to the global conversation on molecular and cellular biology.

CELL AND TISSUE RESEARCH, published by Springer, is a premier journal dedicated to advancing the field of cell biology, histology, pathology, and forensic medicine. With a proud history dating back to its foundation in 1924 and continuing its legacy, this journal has established itself as a vital source for innovative research, facilitating the dissemination of significant findings that contribute to the understanding of cellular and tissue dynamics. Hailing from Germany, the journal exhibits an impressive standing in the academic community with a 2023 impact factor reflected in its category quartiles: Q2 in Cell Biology, Q1 in Histology, and Q1 in Pathology and Forensic Medicine. It ranks notably within multiple Scopus categories, including 32/208 in Pathology and Forensic Medicine and 13/62 in Histology, showcasing its high percentile rankings of 84th and 79th, respectively. Researchers, professionals, and students benefit from its extensive coverage and rigorous peer-review process that ensures the integrity and relevance of its published works, thus making it an essential resource in the scientific community. While it operates under a subscription model, its commitment to quality and impact makes it an indispensable journal for anyone engaged in cellular and tissue research.

The Journal of Stem Cells & Regenerative Medicine is a leading publication dedicated to the advancing field of stem cell research and regenerative medicine. Established in India and published by JOURNAL STEM CELLS & REGENERATIVE MEDICINE, this Open Access journal has been available since 2007, providing researchers and practitioners with free and unrestricted access to high-quality articles. With an ISSN of 0973-7154, the journal is indexed in Scopus, featuring a wide array of topics and insights into biochemistry, biotechnology, cell biology, and molecular biology, as denoted by its relevant quartile rankings. This journal is committed to bridging the gap between laboratory research and clinical applications, making significant contributions to the scientific community. The convergence of innovative studies from 2010 to 2024 positions it as an invaluable resource for those looking to stay at the forefront of stem cell and regenerative medicine research.

Cell Stem Cell, published by CELL PRESS, is a premier journal at the forefront of cellular biology, genetics, and molecular medicine. With an esteemed impact factor and recognized as a Q1 journal in multiple categories including Cell Biology, Genetics, and Molecular Medicine, it offers researchers, professionals, and students rigorous, peer-reviewed articles that shape the future of stem cell research and regenerative medicine. Located in Cambridge, MA, this journal has become an invaluable resource since its inception in 2007 and is committed to disseminating groundbreaking findings that drive innovation and understanding in these critical fields. By consistently ranking within the top percentile of its categories in Scopus, Cell Stem Cell remains an essential platform for scholarly communication, fostering collaboration among leading scientists worldwide. Although the journal does not currently offer open access options, its comprehensive insights are pivotal for anyone engaged in the study of stem cells and their applications.

Organogenesis is a leading journal published by Taylor & Francis Inc, dedicated to advancing the field of developmental biology and regenerative medicine. With an ISSN of 1547-6278 and E-ISSN 1555-8592, this journal spans an extensive research scope that includes embryology, transplantation, and biomedical engineering, distinguishing itself as a crucial platform for researchers and practitioners alike. Its impact is reflected in its performance across various categories in 2023, earning Q3 rankings in Biomedical Engineering and Embryology, Q4 in Developmental Biology, and Q2 in Transplantation, showcasing its reputable standing among peer journals. Moreover, with Scopus rankings indicating strong positioning in the fields of medicine and biochemistry, Organogenesis is essential for those looking to publish or stay updated on pioneering research. The journal facilitates rigorous peer-review and offers a forum for disseminating innovative findings, making it an invaluable resource for academics, professionals, and students committed to understanding the complexities of organism development.

JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS, published by Wiley, is a leading journal in the field of biomaterials and biomedical engineering, with an impact factor reflected in its relevant Scopus rankings—including a Q2 position in Biomedical Engineering and Q3 in Biomaterials for 2023. This journal, with ISSN 1552-4973 and E-ISSN 1552-4981, serves as a vital platform for disseminating pioneering research and innovative applications of biomaterials. Positioned in the United States, it aims to bridge the gap between material science and biological applications, fostering collaboration among researchers, professionals, and students dedicated to advancing technology in healthcare. With a convergence of studies from 2003 to 2024 and a growing focus on open access, the journal ensures greater visibility and accessibility for groundbreaking research. Join us in exploring the dynamic field of biomaterials, as we push the boundaries of science and engineering for improved patient outcomes.

Regenerative Medicine, published by Taylor & Francis Ltd, is a pivotal journal within the field of biomedical research, focusing on the innovative advances in regenerative and restored functions in human health. With an ISSN of 1746-0751 and an E-ISSN of 1746-076X, this esteemed journal boasts a commendable impact factor within its categories, notably holding the Q2 status in Embryology and Q3 in Biomedical Engineering as of 2023. Covering a broad spectrum of topics from stem cell research to tissue engineering, it serves as a crucial platform for interdisciplinary collaboration among researchers, professionals, and students dedicated to the regeneration of tissues and organs. Given its comprehensive scope from 2006 to 2024, the journal continues to attract high-quality manuscripts that advance the frontiers of knowledge in regenerative medicine. Researchers and practitioners alike are encouraged to engage with the latest findings and methodologies disseminated in this vital publication.

Stem Cells and Cloning-Advances and Applications is a leading peer-reviewed journal dedicated to the dynamic fields of stem cell research and cloning technologies. Published by DOVE MEDICAL PRESS LTD in New Zealand since 2008, this Open Access journal ensures that groundbreaking findings are accessible to a global audience. With a focus on innovative applications and advancements in cellular biology, the journal plays a pivotal role in disseminating knowledge within the scientific community. The journal currently holds an impact factor that reflects its influence, with notable rankings in both Cell Biology and Medicine (Miscellaneous), showcasing its interdisciplinary relevance. Researchers, professionals, and students alike benefit from the journal’s wide-ranging contributions, covering critical topics from regenerative medicine to genetic research. With a commitment to fostering collaboration and encouraging discussion in these cutting-edge domains, Stem Cells and Cloning-Advances and Applications continues to be a vital resource for advancing scientific inquiry and application.

Tissue Engineering Part A is a prestigious peer-reviewed journal published by MARY ANN LIEBERT, INC that focuses on innovative research and advancements within the field of tissue engineering and regenerative medicine. Since its inception in 2008, this journal has played a critical role in disseminating cutting-edge findings that bridge the gap between laboratory research and clinical application, underscoring its significance in the scientific community. With a diverse scope encompassing biochemistry, bioengineering, biomaterials, and biomedical engineering, the journal ranks notably in the Scopus database, holding a Q2 quartile status across multiple categories, thus reflecting its high impact on ongoing research and professional practice. For researchers, professionals, and students, Tissue Engineering Part A serves as an invaluable resource, offering insights into the latest methodologies and breakthroughs that drive the future of healthcare and therapeutic strategies. While primarily a subscription-based journal, it ensures that vital research is accessible to a broad audience of scientists and engineers committed to advancing the life sciences.